HIV Citations List: October, 2016

Literature Citations

1. CD4-mimetic Sulfopeptide Conjugates Display Sub-nanomolar anti-HIV-1 Activity and Protect Macaques against a SHIV162P3 Vaginal Challenge. Arien, K.K., F. Baleux, D. Desjardins, F. Porrot, Y.M. Coic, J. Michiels, K. Bouchemal, D. Bonnaffe, T. Bruel, O. Schwartz, R. Le Grand, G. Vanham, N. Dereuddre-Bosquet, and H. Lortat-Jacob. Scientific Reports, 2016. 6(34829): 13pp. PMID[27721488]. PMCID[PMC5056392].
[PubMed]. HIV_10_2016.

2. Enfuvirtide-peg Conjugate: A Potent HIV Fusion Inhibitor with Improved Pharmacokinetic Properties. Cheng, S., Y. Wang, Z. Zhang, X. Lv, G.F. Gao, Y. Shao, L. Ma, and X. Li. European Journal of Medicinal Chemistry, 2016. 121: p. 232-237. PMID[27240277].
[PubMed]. HIV_10_2016.

3. A Cinnamon-derived Procyanidin Compound Displays anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-receptor-binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation. Connell, B.J., S.Y. Chang, E. Prakash, R. Yousfi, V. Mohan, W. Posch, D. Wilflingseder, C. Moog, E.N. Kodama, P. Clayette, and H. Lortat-Jacob. Plos One, 2016. 11(10): p. e0165386. PMID[27788205]. PMCID[PMC5082894].
[PubMed]. HIV_10_2016.

4. An Evolved RNA Recognition Motif That Suppresses HIV-1 Tat/Tar-dependent Transcription. Crawford, D.W., B.D. Blakeley, P.H. Chen, C. Sherpa, S.F.J. Le Grice, I.A. Laird-Offringa, and B.R. McNaughton. ACS Chemical Biology, 2016. 11(8): p. 2206-2215. PMID[27253715].
[PubMed]. HIV_10_2016.

5. Preclinical Evaluation of a Mercaptobenzamide and Its Prodrug for NCp7-Targeted Inhibition of Human Immunodeficiency Virus. Hartman, T.L., L. Yang, A.N. Helfrick, M. Hassink, N.I. Shank, K. George Rosenker, M.T. Scerba, M. Saha, E. Hughes, A.Q. Wang, X. Xu, P. Gupta, R.W. Buckheit, Jr., and D.H. Appella. Antiviral Research, 2016. 134: p. 216-225. PMID[27568924].
[PubMed]. HIV_10_2016.

6. Sulfotyrosine Dipeptide: Synthesis and Evaluation as HIV-Entry Inhibitor. Ju, T., D. Hu, S.H. Xiang, and J. Guo. Bioorganic Chemistry, 2016. 68: p. 105-111. PMID[27475281].
[PubMed]. HIV_10_2016.

7. Identification of Interferon-stimulated Genes with Antiretroviral Activity. Kane, M., T.M. Zang, S.J. Rihn, F.W. Zhang, T. Kueck, M. Alim, J. Schoggins, C.M. Rice, S.J. Wilson, and P.D. Bieniasz. Cell Host & Microbe, 2016. 20(3): p. 392-405. PMID[27631702]. PMCID[PMC5026698].
[PubMed]. HIV_10_2016.

8. In Vitro anti-HIV and Antioxidant Activity of Hoodia gordonii (Apocynaceae), a Commercial Plant Product. Kapewangolo, P., M. Knott, R.E. Shithigona, S.L. Uusiku, and M. Kandawa-Schulz. BMC Complementary and Alternative Medicine, 2016. 16(1): p. 411. PMID[27776523]. PMCID[PMC5078957].
[PubMed]. HIV_10_2016.

9. Sceletium tortuosum Demonstrates in Vitro anti-HIV and Free Radical Scavenging Activity. Kapewangolo, P., T. Tawha, T. Nawinda, M. Knott, and R. Hans. South African Journal of Botany, 2016. 106: p. 140-143. ISI[000383294500021].
[WOS]. HIV_10_2016.

10. Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages. Ma, T.C., R.H. Zhou, X. Wang, J.L. Li, M. Sang, L. Zhou, K. Zhuang, W. Hou, D.Y. Guo, and W.Z. Ho. Scientific Reports, 2016. 6(34752): 10pp. PMID[27734899]. PMCID[PMC5062087].
[PubMed]. HIV_10_2016.

11. Investigational Protease Inhibitors as Antiretroviral Therapies. Midde, N.M., B.J. Patters, P. Rao, T.J. Cory, and S. Kumar. Expert Opinion on Investigational Drugs, 2016. 25(10): p. 1189-1200. PMID[27415449].
[PubMed]. HIV_10_2016.

12. Synthetic alpha-Hydroxytropolones as Inhibitors of HIV Reverse Transcriptase Ribonuclease H Activity. Murelli, R.P., M.P. D'Erasmo, D.R. Hirsch, C. Meck, T. Masaoka, J.A. Wilson, B.F. Zhang, R.K. Pal, E. Gallicchio, J.A. Beutlere, and S.F.J. Le Grice. MedChemComm, 2016. 7(9): p. 1783-1788. ISI[000384256800009].
[WOS]. HIV_10_2016.

13. Article Inhibitory Effect of 2,3,5,6-Tetrafluoro-4-[4-(aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide Derivatives on HIV Reverse Transcriptase Associated RNase H Activities. Pala, N., F. Esposito, D. Rogolino, M. Carcelli, V. Sanna, M. Palomba, L. Naesens, A. Corona, N. Grandi, E. Tramontano, and M. Sechi. International Journal of Molecular Sciences, 2016. 17(8): E1371. PMID[27556447]. PMCID[PMC5000766].
[PubMed]. HIV_10_2016.

14. Indole-based Allosteric Inhibitors of HIV-1 Integrase. Patel, P.A., N. Kvaratskhelia, Y. Mansour, J. Antwi, L. Feng, P. Koneru, M.J. Kobe, N. Jena, G. Shi, M.S. Mohamed, C. Li, J.J. Kessl, and J.R. Fuchs. Bioorganic & Medicinal Chemistry Letters, 2016. 26(19): p. 4748-4752. PMID[27568085]. PMCID[PMC5018460].
[PubMed]. HIV_10_2016.

15. Asymmetric Total Syntheses of Aetheramides and Their Stereoisomers: Stereochemical Assignment of Aetheramides. Qi, N., S.R. Allu, Z.L. Wang, Q. Liu, J. Guo, and Y. He. Organic Letters, 2016. 18(18): p. 4718-4721. PMID[27603759].
[PubMed]. HIV_10_2016.

16. X-ray Crystal and DFT Study of a Potent anti-HIV-1 Agent: 2-(5,5-Dioxido-3-phenylpyrazolo[4,3-c][1,2]benzothiazin-4(2H)-yl)-N'-(3-nitrophenyl)methylidene acetohydrazide. Saif, M.J., M. Ahmad, and N. Idrees. Journal of Theoretical & Computational Chemistry, 2016. 15(1650038): 11pp. ISI[000383786900002].

[WOS]. HIV_10_2016.

17. Novel (2,6-Difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with Restricted Conformation as Potent Non-Nucleoside Reverse Transcriptase Inhibitors against HIV-1. Simon, P., O. Baszczynski, D. Saman, G. Stepan, E. Hu, E.B. Lansdon, P. Jansa, and Z. Janeba. European Journal of Medicinal Chemistry, 2016. 122: p. 185-195. PMID[27371922].
[PubMed]. HIV_10_2016.

18. A Divergent Approach for the Synthesis of D- and L-4'-Ethynyl dioxolane Nucleosides with Potent anti-HIV Activity. Singh, S., V. Gajulapati, M. Kim, J.I. Goo, J.K. Lee, K. Lee, C.K. Lee, L.S. Jeong, and Y. Choi. Synthesis, 2016. 48(18): p. 3050-3056. ISI[000384023400008].
[WOS]. HIV_10_2016.

19. A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity. Urano, E., K. Miyauchi, Y. Kojima, M. Hamatake, S.D. Ablan, S. Fudo, E.O. Freed, T. Hoshino, and J. Komano. ChemMedChem, 2016. 11(20): p. 2320-2326. PMID[27634404].
[PubMed]. HIV_10_2016.

20. Quassinoids: Viral Protein R Inhibitors from Picrasma javanica Bark Collected in Myanmar for HIV Infection. Win, N.N., T. Ito, Y.Y. Win, H. Ngwe, T. Kodama, I. Abe, and H. Morita. Bioorganic & Medicinal Chemistry Letters, 2016. 26(19): p. 4620-4624. PMID[27575477].
[PubMed]. HIV_10_2016.

Patent Citations

21. Preparation of Novel C-3 Triterpenones with C-28 Amide Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, G.L.D. Krupadanam, P.R. Adulla, E.R. Bammidi, B.R. Kasireddy, and S. Neela. Patent. 2016. 2016-IB51424 2016147099: 86pp.

[Patent]. HIV_10_2016.

22. Pyrone Derivatives for Use as Antiviral Agents. Brack-Werner, R., M. Helfer, M. Roesner, M. Schneider, U. Protzer, C. Hertweck, and M. Werneburg. Patent. 2016. 2016-EP57598 2016162405: 109pp.

[Patent]. HIV_10_2016.

23. Preparation of Polycyclic-carbamoylpyridone Compounds and Their Pharmaceutical Use. Cai, Z.R., H. Jin, S.E. Lazerwith, and H.-J. Pyun. Patent. 2016. 2016-US25740 2016161382: 120pp.

[Patent]. HIV_10_2016.

24. Preparation of a Coumarin Derivative as an Antiviral Agent, Pharmaceutical Composition Thereof and Its Use. Trkovnik, M., M. Cacic, and J. Rizvani. Patent. 2016. 2016-HR5 2016156888: 60pp.

[Patent]. HIV_10_2016.

25. Phosphate-substituted Quinolizine Derivatives Useful as HIV Integrase Inhibitors and Their Preparation. Yu, T., S.T. Waddell, J.A. McCauley, T.H. Graham, H. Li, I. Raheem, and J.A. Grobler. Patent. 2016. 2016-US24193 2016154527: 127pp.

[Patent]. HIV_10_2016.